you're describing the entire OTC. regulators could find a more retail-friendly approach. contracts for note-holders are, and have been, ridiculous terms. floorless toxics should be totally illegal.
multiple RS should be illegal.
and the answer to a crooked CEO should never be a suspension that wipes out retail, while the management who perpetrated the crime gets to fire up a new ticker, load it with toxic debt, and do it all over again.
Market Data 
Markets 
AI
